Pharmacy resources

September 1st, 2024: long-acting buprenorphine injections (Sublocade and Brixadi) are now covered on the pharmacy benefit for OHP without a prior authorization. This means Sublocade and Brixadi can be dispensed at pharmacies instead of only being available through buy-and-bill. Sublocade and Brixadi are still covered through buy-and-bill without a prior authorization. When dispensed from a pharmacy, Sublocade and Brixadi have quantity limits that must be met. If prescriptions are written for incorrect quantities and/or day supplies, claims may not pay. If these quantity limits need to be exceeded, a prior authorization is required. Please refer to the FDA labeling for Sublocade and Brixadi for dosing.

Quantity Limits:

Sublocade (FDA Label)

• 300mg dose: 300mg every 4 weeks (1.5 mL every 4 weeks)
• 100mg: 100mg every 4 weeks (0.5 mL every 4 weeks)

Brixadi (FDA Label)

• 8mg weekly dose: 8mg every 7 days (0.16mL every 7 days)
• 16mg weekly dose: 16mg every 7 days (0.32mL every 7 days)
• 24mg weekly dose: 24mg every 7 days (0.48mL every 7 days)
• 32mg weekly dose: 32mg every 7 days (0.64mL every 7 days)
• 64mg monthly dose: 64mg every 4 weeks (0.18mL every 4 weeks)
• 96mg monthly dose: 96mg every 4 weeks (0.27mL every 4 weeks)
• 128mg monthly dose: 128mg every 4 weeks (0.36mL every 4 weeks)